tradingkey.logo

Cibus Inc

CBUS
1.710USD
+0.170+11.04%
Close 12/19, 16:00ETQuotes delayed by 15 min
89.89MMarket Cap
LossP/E TTM

Cibus Inc

1.710
+0.170+11.04%

More Details of Cibus Inc Company

Cibus, Inc. is an agricultural technology company that uses gene-editing technologies to develop plant traits in seeds. Its business is the development of plant traits for some of the agricultural food crops that help address specific productivity, profitability, sustainability, or yield challenges in farming. Its core technology propriety gene editing platform is called the Rapid Trait Development System (RTDS). It is the underlying technology in the Company's Trait Machine process, an end-to-end semi-automated high-throughput gene editing system that directly edits seed companies' elite germplasm. It has a pipeline of five productivity traits. It has developed the productivity trait Pod Shatter Reduction (PSR) in Canola and Winter Oilseed Rape (WOSR) strengthens the sheath around the canola seeds. Its advanced productivity traits, Sclerotinia resistance and HT2 in Canola and WOSR, continue to progress and offer white mold disease resistance and broadleaf weed herbicide tolerance.

Cibus Inc Info

Ticker SymbolCBUS
Company nameCibus Inc
IPO dateJul 20, 2017
CEOBeetham (Peter Ronald)
Number of employees157
Security typeOrdinary Share
Fiscal year-endJul 20
Address6455 Nancy Ridge Drive
CitySAN DIEGO
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92121
Phone18584500008
Websitehttps://www.cibus.com/
Ticker SymbolCBUS
IPO dateJul 20, 2017
CEOBeetham (Peter Ronald)

Company Executives of Cibus Inc

Name
Name/Position
Position
Shareholding
Change
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%
Ms. Kimberly Ann (Kim) Box
Ms. Kimberly Ann (Kim) Box
Director
Director
--
--
Mr. Cornelis (Carlo) Broos
Mr. Cornelis (Carlo) Broos
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Craig Wichner
Mr. Craig Wichner
Director
Director
--
--
Mr. August J. Moretti, J.D.
Mr. August J. Moretti, J.D.
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Rory B. Riggs
Mr. Rory B. Riggs
Chairman of the Board, Co-Founder
Chairman of the Board, Co-Founder
14.63M
+396.82%
Dr. Peter Ronald Beetham, Ph.D.
Dr. Peter Ronald Beetham, Ph.D.
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
President, Interim Chief Executive Officer, Co-Founder, Chief Operating Officer, Director
382.44K
--
Dr. Greg Gocal, Ph.D.
Dr. Greg Gocal, Ph.D.
Co-Founder, Executive Vice President, Chief Scientific Officer
Co-Founder, Executive Vice President, Chief Scientific Officer
374.84K
+19.06%
Mr. Jason Stokes, Esq.
Mr. Jason Stokes, Esq.
Chief Legal Officer, General Counsel and Corporate Secretary
Chief Legal Officer, General Counsel and Corporate Secretary
127.67K
--
Ms. Noel Sauer, Ph.D.
Ms. Noel Sauer, Ph.D.
Senior Vice President - Research
Senior Vice President - Research
105.48K
--
Dr. Gerhard Prante, Ph.D.
Dr. Gerhard Prante, Ph.D.
Independent Director
Independent Director
40.20K
+421.56%

Revenue Breakdown

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2023
Relevant data have not been disclosed by the company yet.
By RegionUSD
Name
Revenue
Proportion
United States
933.00K
0.00%
By Business
By Region
Relevant data have not been disclosed by the company yet.

Shareholding Stats

Updated: Mon, Nov 17
Updated: Mon, Nov 17
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Riggs (Rory B)
27.75%
Fidelity Management & Research Company LLC
13.93%
JPL Investments SA
3.18%
Vantage Consulting Group, Inc.
2.17%
The Vanguard Group, Inc.
1.83%
Other
51.14%
Shareholders
Shareholders
Proportion
Riggs (Rory B)
27.75%
Fidelity Management & Research Company LLC
13.93%
JPL Investments SA
3.18%
Vantage Consulting Group, Inc.
2.17%
The Vanguard Group, Inc.
1.83%
Other
51.14%
Shareholder Types
Shareholders
Proportion
Individual Investor
30.16%
Investment Advisor
17.15%
Corporation
3.25%
Investment Advisor/Hedge Fund
3.06%
Hedge Fund
0.89%
Family Office
0.21%
Research Firm
0.18%
Venture Capital
0.13%
Bank and Trust
0.10%
Other
44.87%

Institutional Shareholding

Updated: Mon, Dec 8
Updated: Mon, Dec 8
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
155
11.44M
29.24%
--
2025Q3
160
11.44M
29.36%
-1.15M
2025Q2
160
12.59M
24.13%
+683.12K
2025Q1
154
11.90M
30.83%
+1.84M
2024Q4
150
9.30M
35.60%
+430.74K
2024Q3
137
8.87M
33.20%
+582.16K
2024Q2
125
8.28M
27.75%
+2.07M
2024Q1
106
6.21M
28.39%
+246.00K
2023Q4
96
5.70M
24.18%
+956.24K
2023Q3
100
4.74M
25.36%
+638.98K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Riggs (Rory B)
14.63M
27.84%
+11.68M
+396.82%
Jun 09, 2025
Fidelity Management & Research Company LLC
7.17M
13.64%
+2.57M
+55.97%
Jun 30, 2025
JPL Investments SA
1.67M
3.19%
-12.28K
-0.73%
Mar 24, 2025
Vantage Consulting Group, Inc.
1.14M
2.18%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
856.15K
1.63%
-35.97K
-4.03%
Jun 30, 2025
Beetham (Peter Ronald)
382.44K
0.73%
--
--
Mar 24, 2025
Gocal (Gregory Francis William)
374.84K
0.71%
+60.00K
+19.06%
Mar 24, 2025
BlackRock Institutional Trust Company, N.A.
456.21K
0.87%
-575.56K
-55.78%
Jun 30, 2025
Geode Capital Management, L.L.C.
257.74K
0.49%
-215.87K
-45.58%
Jun 30, 2025
Certior Financial Group, LLC
173.56K
0.33%
+27.21K
+18.59%
Jun 30, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
iShares Micro-Cap ETF
0.01%
iShares Russell 2000 Value ETF
0%
Global X Russell 2000 ETF
0%
Proshares Ultra Russell 2000
0%
ProShares UltraPro Russell2000
0%
ProShares Hedge Replication ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Russell 2000 ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
iShares Russell 2000 Value ETF
Proportion0%
Global X Russell 2000 ETF
Proportion0%
Proshares Ultra Russell 2000
Proportion0%
ProShares UltraPro Russell2000
Proportion0%
ProShares Hedge Replication ETF
Proportion0%
iShares Core S&P Total U.S. Stock Market ETF
Proportion0%
iShares Russell 2000 ETF
Proportion0%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Split

Date
Type
Ratio
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1
Date
Type
Ratio
Jun 01, 2023
Merger
5→1
Apr 07, 2023
Merger
10→1

FAQs

Who are the top five shareholders of Cibus Inc?

The top five shareholders of Cibus Inc are:
Riggs (Rory B) holds 14.63M shares, accounting for 27.84% of the total shares.
Fidelity Management & Research Company LLC holds 7.17M shares, accounting for 13.64% of the total shares.
JPL Investments SA holds 1.67M shares, accounting for 3.19% of the total shares.
Vantage Consulting Group, Inc. holds 1.14M shares, accounting for 2.18% of the total shares.
The Vanguard Group, Inc. holds 856.15K shares, accounting for 1.63% of the total shares.

What are the top three shareholder types of Cibus Inc?

The top three shareholder types of Cibus Inc are:
Riggs (Rory B)
Fidelity Management & Research Company LLC
JPL Investments SA

How many institutions hold shares of Cibus Inc (CBUS)?

As of 2025Q4, 155 institutions hold shares of Cibus Inc, with a combined market value of approximately 11.44M, accounting for 29.24% of the total shares. Compared to 2025Q3, institutional shareholding has increased by -0.12%.

What is the biggest source of revenue for Cibus Inc?

In FY2025Q2, the -- business generated the highest revenue for Cibus Inc, amounting to -- and accounting for --% of total revenue.
KeyAI